15th ESC Congress

The 15th ESC Congress "Family planning and contraception from  adolescence to the menopause' was held in Budapest, 9-12 May 2018

Selected Keynote Lectures and Congress Sessions will be available on webcast

To view a powerpoint presentation click on the title of the presentation.

All abstracts are available in the Book of Abstracts.

Keynote lectures

Technology & basic science: introduction and overview • K. Gemzell Danielsson (Sweden)

Quality of services: overview about standards of care, content of services, principles of training and possible indicators for evaluation and measurement • J. Bitzer (Switzerland) 

History of birth control • J.J. Amy (Belgium)

Congress sessions

CONSES 01 Technology & basic science: From bench-to bed-to the hand of women
New delivery systems in contraception • R. Sitruk Ware (USA)

CONSES 02 Clinical practice: Life course approach -Contraception in the perimenopause

Safety of estradiol containing combined hormonal contraceptives in perimenopausal women • A. Gompel (France)

Mental disorders during perimenopause and comorbid sexual dysfunction • C. Soares (Canada)

When to stop contraception: how to identify menopause in POP and CHC users • C. Kreutzer (Romania)

CONSES 03 General/other: Economics and Epidemiology of Contraception

The economic benefits of meeting unmet need for contraception • J. Trussell (USA)

Contraceptives reimbursement: different public policies within Europe - which evidence? • M. Oliveira da Silva (Portugal)

Challenges in contraceptive epidemiology • H. de Barros (Portugal)

CONSES 04 Culture & Policies: Culture and religion

Gynaecological health care in immigrants (incl contraception) • S. Kalantaridou (Greece)

Cultural diversity of sexuality education in Europe • G. Lazdane (Latvia)

CONSES 05 Clinical practice: Gynaecological disorders

PCOS: Intervention possibilities • S. Skouby (Denmark)

Is Premenstrual syndrome (PMS) / Premenstrual dysphoric disorder (PMDD) due to paradoxical effects of progesterone metabolites and possible to treat? • T. Bäckström (Sweden)

Adenomyosis: a challenging condition from adolescence till the menopause • M. Correa Rancel (Spain)

CONSES 06 Clinical practice: Systemic medical conditions - Reproductive Health for young women with long-term illness

Contraception for the obese woman • R. Sitruk Ware (USA)

Contraception, HIV and STI • G.A. Grebennikova (Kazakhstan)

Autoimmune disease, contraception and reproduction • D. Lazaris (Greece)

CONSES 07 Technology & basic science: Emergency contraception

Facts and myths around Emergency Contraception: EC use in adolescents, repeated and peri-coital use of EC pills and advanced provision • N. Envall (Sweden)

Access to EC: trends in use, persistent challenges and new solutions • K. Cleland (USA)

CONSES 08 Quality of services: Components of quality: training, service delivery and research

Education and training across Europe • K. Sedlecky (Serbia)

Models of Sexual and Reproductive Healthcare, UK • A. Kasliwal (UK)

Indicators and Research • M. Ali (WHO)

CONSES 09 Clinical practice: Life course approach - Postpartum and postabortum

Postabortion contraception • O. Heikinheimo (Finland)

CONSES 10 Technology & basic science: Permanent contraception

Male sterilisation as an alternative and contribution • F. Roumen (the Netherlands)

Should we still perform tubal ligation instead of salpingectomy at the time of female sterilisation? • P. Lobo (Spain)

CONSES 11 Clinical practice: IUD

The Intrauterine ball and Gynefix: Are they superior to T-shaped 3. generation copper devices? • A. Ber (israel)

Potential problems and concerns about IUD insertion associated with high risk HPV and HIV infection • I. Lete Lasa (Spain)

Length of endometrial cavity and other risk factors for IUD displacement, expulsion and reexpulsion • L. Bahamondes (Brazil)

CONSES 12 Clinical practice: Transgender health care

Principles of transgender care, samples of best practices in Europe and how reproductive/sexual health care providers might contribute • P. De Sutter (Belgium)

Dilemmas in transgender health care with special focus on the very young and very old • M. van Trotsenburg (Austria)

Gynaecological aspects of treatment and follow-up of transsexual individual • S. Weyers (Belgium)

CONSES 13 Clinical practice - Life course approach: Adolescents

Adolescent gynaecology made simple • J. Dickson (UK)

LARC for adolescents • D. Apter (Finland)

Sexuality education • K. Haldre (Estonia)

CONSES 14 Culture & Policies: Contraception and mental and sexual health

Contraception and mental health • Ö. Lidegaard (Denmark)

Prospective placebo controlled trials on COC and impact on sexual and mental health • I. Sundström Poromaa (Sweden)

The Contraceptive Paradox - Society and impact of contraception on sexual and mental health • C. Fiala (Austria)

CONSES 15 Culture & Policies: Human rights (HR) and FP & RH - Joint ESC - WHO

Overview of the process and outcome on development of the European Sexual and Reproductive Health Action Plan • G. Lazdane (WHO) 

Barriers on access to FP and other RH services in Europe: Providers perspective • T. Bombas (Portugal)

International and European jurisprudence on reproductive health and rights • K. Thomasen (Denmark) 

 CONSES 16 Quality of services: The web and social media

Social media: friend or foe? • J. Dickson (UK)

Web based sexual health education • P. Baraitser (UK)

Moving contraceptive services online: models of care • T. van Every (UK)

CONSES 17 Clinical practice: New developments

Vaccination: an update on the global/European HPV programmes and risk of autoimmune conditions • J. Mehlsen (Denmark)

Prevention and control of chlamydia in Europe – from data to policies and testing recommendations • O. Mårdh (ECDC)

WHOs response to Zika epidemic – a review of contraceptive sales in the setting of the Zika virus epidemic • M. Ali (WHO)

Expert group

EGSES 01 Expert Group on STI: How to inform and reach women about STI in the different age groups

Issues around STI and sexual abuse • Gilbert Donders (Belgium)

Communication about sexuality in adolescence • S. Reuter (UK)

EGSES 02 Expert Group on Non-hormonal methods of contraception: IUDs and natural methods of family planning

New developments in IUDs • D. Hubacher (USA)

Typical reasons for removal of Cu releasing and hormone releasing IUDs • L. Bahamondes (Brazil) 

Natural methods • P. Frank-Hermann (Germany)

EGSES 03 Expert Group on Sexual Medicine and Sex Education: Gender and sexual health

Contraceptive choices for specific social groups • K. Sedlecky (Serbia) and T. Bombas (Portugal)

Screening sexual violence during family planning counselling • A. Kapamadžija (Serbia)

EGSES 04 Expert Group on Future of Hormonal and Molecular Contraception: Contraception after cancer

Hormonal contraception after breast cancer and overian cancer • A. Gompel (France)

Endometrial cancer and contraception • A. Mueck (Germany)

Contraception after non-gynecological cancers • A. Cagnacci (Italy)

Joint session

JOINSES 01 Technology & basic science: ESC - ICMC: Male contraception

Combined injection NETE+TU for male contraception • M. Festin (WHO)

The male pill • D. Blithe (USA)

JOINSES 02 ESC - ISPOG: Good peri-abortion care from a bio-psycho-social perspective

Peri-abortion care: When is it too much and when too little? • S. Tschudin (Switzerland)

What are women’s emotional needs? - Evidence and practice • H. Rowe (Australia)

Peri-abortion counselling and care in case of congenital anomalies and chromosomal abnormalities • M. Paarlberg (the Netherlands)

JOINSES 03 ESC Expert group on abortion and FIAPAC

Restrictions to access to abortion • S. Rowlands (UK)

Safe options for women • K. Gemzell Danielsson (Sweden)

Training of providers • S. Cameron (UK)

JOINSES 04 ESC - CIC: Latinamerica, advances and problems

Legislation on contraception and abortion in Latinamerica • L. Ferreira Vicente (Portugal)

Medical termination of pregnancy in Latinamerica • R. Schiavon (Mexico)

Iberoamerican master on contraception, sexual and reproductive health • R. Lertxundi (Spain)

JOINSES 05 ESC - EHF: Menstrual and hormonal Migraines / Risks and benefits associated with use of hormonal contraceptives

How to diagnose tension-type headache, migraine and menstrually-related migraine • P. Martelletti (Italy)

Cardiovascular risks associated with migraine and use of combined hormonal contraception (and mulitplication of risks with smoking, hypertension, use of combined hormonal contraceptives) • L. Vécsei (Hungary)

Progestin-only contraception and beneficial effects on migraine • G. Merki (Switzerland)

Combined hormonal contraception and migraine, WHO and EHF/ESCRH criteria and balancing risks and benefit • S. Sacco (Italy)

JOINSES 06 ESC UNFPA EEIRH: Eastern Europe

“Choices, not chances” – UNFPA support to achieve universal access to family planning in EECA countries • T. Khomasuridze (UNFPA)

The Virtual Contraceptive Consultation (ViC) online platform: developing capacity for evidence-based and rights-based family planning in Eastern Europe and Central Asia • M. Horga (EEIRH)

ESC activities in Eastern European countries • G. Merki (Switzerland)

JOINSES 07 ESC ISGE: Menopausal transition: a period where COC and androgens can have a major role

Do CHCs help mood an sexual well-being before menopause transition? • R. Nappi (Italy)

JOINSES 08 ESC FSRH: Evidence based service delivery - using public health and clinical evidence for effectiveness

Developing evidence-based contraceptive guidance that is useful in practice • S. Hardman (UK)

European guideline development or reporting adverse events to help support future guidance • K. Gersak (Slovenia)

JOINSES 09 WHO IPPF: From evidence to guidance to action in contraception

Risk of STIs and use of hormonal contraception – a review of the literature • M. Festin (WHO)

The WHO Selected Practice Recommendations for contraceptive use, 3rd edition: Ensuring safe and effective contraceptive services • M.L. Gaffield (WHO)

App instant messaging to increase acceptability of effective contraception among young people in Tajikistan: results from a randomised controlled trial • O. McCarthy (UK) • R. Tohirov (Tajikistan)

JOINSES 10 ESC - SEG: Gynecological endocrinology and contraception

PCO - enigma and challenge • S. Skouby (Denmark)

Male contraception - endocrine concepts • C. Wang (USA)

JOINSES 11 ESC - EBCOG: Collaboration in Sexual and Reproductive Health education: EBCOG and ESC

EBCOG Standards of Care in Sexual and Reproductive Health (SRH) • T. Mahmood (UK)

Challenges of Contraception Provision in EECA Region • T. Khomasuridze (UNFPA)

Capacity building in EECA Region to address SRH Service Provision • J. Bitzer (Switzerland)

Quality assurance of Future Specialists in SRH in Europe • R. Kirschner (Norway)

Society sessions

SOCSES 01 Session of the French-speaking Society of Contraception

Humour: a disposition of mind or feeling. It also applies to contraception • J.J. Amy (Belgium)

Hormonophobia and contraception. How can we react? • J. Bitzer (Switzerland)

Contraception in overweight and obese women • D. Serfaty (France)

SOCSES 02 Hungarian Society of Obst/gyn: Contraception in Hungary: history, present and future

The history of contraception in Hungary • N. Ács (Hungary)

Future perspectives in Hungarian contraception • T. Major (Hungary)

SOCSES 03 Romanian Society of Obst/gyn: Romanian crossroads in contraception

Family planning and contraception in Romania. 27 years of experience: results and challenges • M. Horga (Romania)

Current trends and good medical practice in contraception for fertile age women • N. Suciu (Romania)

Meet the expert sessions

MTE 03 Clinical practice: Clinical cases • K. Sedlecky (Serbia) • F. Mehmedovic (Bosnia & Herzegovina) • A. Kapamadžija (Serbia) 

Late breaking news

New developments in LNG-IUS: The small 5-year low-dose levonorgestrel device (LNG-IUS 12). Clarification of the role in comparison to the LNG-IUS 20 • A. Nelson (USA)

A new drospirenone only pill: Phase III trial data: Desogestrel 75 mcg vs Drospirenone 4mg • A. Kubba (UK)

Is there an evidence for negative effects of hormonal contraceptives on mood • G. Merki (Switzerland)

What women want and what they get - patients and gynaecologists’ views on contraceptive counselling • J. Bitzer (Switzerland)

Granted projects

Delivery of audiovisual information on early medical abortion care to women via tablet • J. Reynolds-Wright (UK)

Men speak out: engaging men in female genital mutilation - prevention in Europe • F. Richard (Belgium)

Emergency contraception in Albania: A multi-methods study of awareness, attitudes and practices • F. Doci (Canada/Albania)

Free communications - Young scientists

Implementing a venous thromboembolism risk assessment in an abortion service • F. von Hawrylak (UK)

The modulation of progestins in the RNA expression of progesterone and glucocorticoid receptors in endometrial stromal cells exposed to inflammation • G. Grandi (Italy)

Weight gain associated with LARC method use within a racially diverse patient population • R. Hattiangadi (USA)

Health care differences across Europe concerning routine check-up of perforation risk with intrauterine devices: results of the EURAS-IUD study • P. De Corte (Germany)

Don’t mention the “S” Word! • A. Forsythe (UK)

Free communications

Effects of Estetrol on Thrombotic and Growth Parameters Associated with Vascular Remodelling • R. Dubey (Switzerland

Targeting contraceptive advice and supply in community settings: development of a clinical prediction rule using psychosocial questions • N. Edelman (UK)

Cardiovascular Safety in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study • K. Heinemann (Germany)

Does salpingectomy provide further cancer risk reduction in women without a deleterious BRCA1/2 variant? • L. Shulman (USA)

Sexually Transmitted Infections – The experience of an Adolescents’Unit • M. Brito (Portugal)

Pharmacokinetic profile of oral desogestrel before and after gastric by pass surgery • C. Ginstman (Sweden)

Contraception for women with cardiac disease • C. Gouveia (Brazil)

Developing a contraceptive counselling online learning course • P. Baraitser (UK)

Culture- and PCR–based detection of BV associated bacteria in the biofilm of removed IUDs • M. Szucs (Hungary)

Dimensional analysis of the endometrial cavity: how many dimensions should the ideal intrauterine device or system have? • N. Goldstuck (South Africa)

Predictors of Unscheduled Spotting and Bleeding in Women using Oral Drospirenone 4.0 mg for Contraception • D. Archer (USA)

Comics for contraception education in young adults: results from a quasi-experimental study • A. Sridhar (USA)

Pilot Center for Victims of Sexual Violence at Clinic for Gynaecology and Obstetrics -Clinical Center of Vojvodina in Novi Sad • K. Kričković Pele (Serbia)

Providing telemedicine abortion care in Poland: An analysis of 18 months of service delivery through Women Help Women • A. Foster (Canada)

Hormonal contraception and female sexuality: analysis of the FECOND survey • P. Mourey (France)

Fake news and contraception: mis- and disinformation concerning contraception in the internet and social media • D. Seidman (Israel)

Adolescent girls need for improved sexual education in Hungary • A. Varga-Tóth (Hungary)

Research integrated with policy makers: real-time health policy and service improvements during “CART- Mifepristone Implementation Research”, Canada • W. Norman (Canada)

The provision of free-of-charge LARC methods and the risk of unintended pregnancy – a register based cohort study • F. Gyllenberg (Finland)

The EC wheel: A tool to promote choice and evidence-based counselling on emergency contraception • C. Puig Borras (Spain)

Male perceptions, knowledge and experiences of accessing emergency contraception in the South African setting • M. Beksinka (South Africa)

Trends and uptake of Immediate Post-partum Long Acting Reversible Contraception Services in a Tertiary Teaching Hospital in Kenya • R. Mogeni (Kenya)

A retrospective multicenter study on the characteristics of women with repeat induced abortions in the Netherlands in 2015 • S. Kroeze (Netherlands)

Assessment of sexual-reproductive health in women with severe-moderate psychiatric pathology • M.A. Obiol (Spain)

Factors influencing the sexual and reproductive health of Muslim women - a systematic review • N. Alomair (UK)

Sexuality Education in Europe and Central Asia: An overview of 25 Countries • E. Ketting (the Netherlands)

                                                                                                                                            

  • All presentations are protected by copyright and meant either for personal viewing or for educational purposes only.
  • All powerpoints were up to date at the time of the presentation. Be aware of scientific progress since then.
  • Reproduction of information for commercial purposes is not allowed without written permission from the ESC Central Office.
  • The content of the presentations does not always reflect the opinion of the ESC.
  • The ESC accepts no liability for the content of the presentations.

 

 

 

Become a member

Poll

Do you wish to have a membership only forum on the ESC website?
Yes
80%
No
20%
Total votes: 10

Facebook